ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1182

The Performance Of a Diagnostic Rule For Acute Gouty Arthritis Without Joint Fluid Analysis: a Validation Study

Laura Kienhorst1, Hein Janssens2, Jaap Fransen3 and Matthijs Janssen1, 1Department of Rheumatology, Rijnstate Hospital, Arnhem, Netherlands, 2Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Diagnosis and gout, Validity

  • Tweet
  • Email
  • Print
Session Information

Title: Metabolic and Crystal Arthropathies I

Session Type: Abstract Submissions (ACR)

Background/Purpose: The gold standard to diagnose gout is the identification of monosodium urate (MSU) crystals in joint fluid. In primary care gout is mostly diagnosed clinically without joint fluid analysis. However, this clinical diagnosis of gout has a positive and negative predictive value of 0.64 and 0.87, respectively.1 To improve the clinical diagnosis of gout a diagnostic rule has been developed in a primary care population.1 The aim of this study is to validate this diagnostic rule in a secondary care population. Methods: In this validation study adult patients who were referred to the rheumatology department from 1 January 2011 until 8 May 2013 with signs and symptoms of monoarthritis at their first visit and who conceivably could have gout were included. The affected joint was aspirated and joint fluid analysis was performed for the presence of MSU crystals. The seven variables of the diagnostic rule (male sex, previous patient-reported arthritis attack, onset within one day, joint redness, first metatarsophalangeal joint involvement, hypertension or one or more cardiovascular diseases, and serum uric acid >0.35 mmol/L) were collected and scored without knowledge of the joint fluid analysis result. The performance of the diagnostic rule was compared to the presence of MSU crystals. Results: 390 patients were included in this study. In 218 (56%) patients MSU crystals were found. As confirmed by the presence of MSU crystals, the prevalences of gout at the cut-off scores ≤4, >4 to <8, and ≥8 points were 6% (4 of 69), 46% (76 of 163), and 88% (138 of 157), respectively. The area under the receiver operator characteristic curve for the diagnostic rule was 0.85 (figure 1). The Hosmer-Lemeshow goodness-of-fit test showed that the difference between the expected and the observed probability was non-significant (p=0.64), indicating well agreement. Conclusion: The diagnostic rule to diagnose gout without joint fluid analysis, which was developed in a primary care population, has a good performance in a secondary care population. References: 1H.J.E.M. Janssens, et al. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis, Arch Intern Med. 2010; 170(13):1120-6.

 


Disclosure:

L. Kienhorst,
None;

H. Janssens,
None;

J. Fransen,
None;

M. Janssen,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-performance-of-a-diagnostic-rule-for-acute-gouty-arthritis-without-joint-fluid-analysis-a-validation-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology